MLTX Share Price Performance
US$9.12
-39.82 (-81.36%)
Price US$9.12
Share PriceUS$9.12
MoonLake Immunotherapeutics Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 8 Fair Values set on narratives written by author
MLTX Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
MoonLake Immunotherapeutics Key Details
About MLTX
- Founded
- 2021
- Employees
- 100
- CEO
- WebsiteView website
MoonLake Immunotherapeutics, a clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.
